We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
–
AUM
$1.28B
AUM Growth
+$191M
Cap. Flow
+$105M
Cap. Flow %
8.22%
Top 10 Hldgs %
34.39%
Holding
1,417
New
100
Increased
350
Reduced
268
Closed
101

Top Buys

Rank Stock Value
1
VT icon
Vanguard Total World Stock ETF
VT
+$19.2M
2
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$16.2M
3
JEPI icon
JPMorgan Equity Premium Income ETF
JEPI
+$12.6M
4
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$11M
5
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$7.21M

Top Sells

Rank Stock Value
1
STE icon
Steris
STE
+$2.55M
2
XOM icon
ExxonMobil
XOM
+$1.59M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$1.37M
4
GLD icon
SPDR Gold Trust
GLD
+$1.37M
5
META icon
Meta Platforms (Facebook)
META
+$864K

Sector Composition

Rank Sector Weight
1 Technology 10.56%
2 Financials 8.34%
3 Healthcare 7.13%
4 Industrials 5.01%
5 Consumer Staples 4.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNI icon
1076
Magnite
MGNI
$2.65B
$2.22K ﹤0.01%
210
– –
MASI
1077
DELISTED
Masimo
MASI
$2.22K ﹤0.01%
15
– –
SBLK icon
1078
Star Bulk Carriers
SBLK
$3.14B
$2.2K ﹤0.01%
115
+7
+6% +$136
FNX icon
1079
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.38B
$2.2K ﹤0.01%
+25
New +$2.21K
PI icon
1080
Impinj
PI
$3.89B
$2.18K ﹤0.01%
20
– –
TVRD
1081
Tvardi Therapeutics
TVRD
$23.5M
$2.15K ﹤0.01%
6
– –
USLM icon
1082
United States Lime & Minerals
USLM
$3.18B
$2.14K ﹤0.01%
75
– –
STNE icon
1083
StoneCo
STNE
$2.62B
$2.12K ﹤0.01%
225
+125
+125% +$1.31K
KSCP icon
1084
Knightscope
KSCP
$25M
$2.09K ﹤0.01%
22
– –
XFOR icon
1085
X4 Pharmaceuticals
XFOR
$363M
$2.08K ﹤0.01%
70
– –
AGNC icon
1086
AGNC Investment
AGNC
$12.3B
$2.07K ﹤0.01%
200
– –
SPIB icon
1087
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$2.07K ﹤0.01%
65
– –
SMCI icon
1088
Super Micro Computer
SMCI
$19.5B
$2.05K ﹤0.01%
250
– –
CVCO icon
1089
Cavco Industries
CVCO
$4.39B
$2.04K ﹤0.01%
+9
New +$2K
FLGT icon
1090
Fulgent Genetics
FLGT
$559M
$2.02K ﹤0.01%
68
– –
XRTX
1091
XORTX Therapeutics
XRTX
$3.5M
$2.02K ﹤0.01%
6
– –
SAM icon
1092
Boston Beer
SAM
$1.88B
$1.98K ﹤0.01%
+6
New +$2.18K
EXPD icon
1093
Expeditors International
EXPD
$22.9B
$1.97K ﹤0.01%
+19
New +$1.96K
IWX icon
1094
iShares Russell Top 200 Value ETF
IWX
$4.03B
$1.95K ﹤0.01%
30
– –
SNBR
1095
DELISTED
Sleep Number
SNBR
$1.95K ﹤0.01%
75
– –
DRI icon
1096
Darden Restaurants
DRI
$22.5B
$1.94K ﹤0.01%
+14
New +$1.95K
CADE
1097
DELISTED
Cadence Bank
CADE
$1.92K ﹤0.01%
+78
New +$2.09K
JAZZ icon
1098
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.91K ﹤0.01%
12
– –
WAB icon
1099
Wabtec
WAB
$51.1B
$1.9K ﹤0.01%
19
– –
FPX icon
1100
First Trust US Equity Opportunities ETF
FPX
$1.51B
$1.89K ﹤0.01%
+24
New +$2.01K
42 43
44
45 46

Similar funds

HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

Clearstead Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Clearstead Advisors held 1,417 positions worth $1.28B, up 18% from $1.09B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Clearstead Advisors deployed $105M of net new capital in Q4 2022, opening 100 new positions and adding to 350 existing holdings. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 161,400 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Steris, an estimated $2.55M trimmed.

  • Clearstead Advisors's largest Q4 2022 buy was iShares 0-3 Month Treasury Bond ETF: 161,400 shares worth $16.2M.
  • Clearstead Advisors added most to Vanguard Total World Stock ETF in Q4 2022, an estimated $19.2M increase.
  • Clearstead Advisors's biggest Q4 2022 reduction was Steris, cutting an estimated $2.55M.
  • Clearstead Advisors fully exited Azenta in Q4 2022, selling an estimated $328K.
  • Clearstead Advisors's ten largest holdings make up 34% of its $1.28B portfolio in Q4 2022.
  • Clearstead Advisors opened 100 new positions and closed 101 in Q4 2022.
  • Clearstead Advisors's portfolio value rose 18% quarter-over-quarter to $1.28B.

Based on Clearstead Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.